Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib

BACKGROUND: Soft tissue sarcomas (STS) are a rare type of malignancy comprising a variety of histological diagnoses. Chemotherapy constitutes the standard treatment for advanced STS. Doxorubicin-based regimens, which include the administration of doxorubicin alone or in combination with ifosfamide o...

Descripción completa

Detalles Bibliográficos
Autores principales: Endo, Makoto, Kataoka, Tomoko, Fujiwara, Toshifumi, Tsukushi, Satoshi, Takahashi, Masanobu, Kobayashi, Eisuke, Yamada, Yoko, Tanaka, Takaaki, Nezu, Yutaka, Hiraga, Hiroaki, Wasa, Junji, Nagano, Akihito, Nakano, Kenji, Nakayama, Robert, Hamada, Tetsuya, Kawano, Masanori, Torigoe, Tomoaki, Sakamoto, Akio, Asanuma, Kunihiro, Morii, Takeshi, Machida, Ryunosuke, Sekino, Yuta, Fukuda, Haruhiko, Oda, Yoshinao, Ozaki, Toshifumi, Tanaka, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996999/
https://www.ncbi.nlm.nih.gov/pubmed/36890471
http://dx.doi.org/10.1186/s12885-023-10693-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996999/
https://www.ncbi.nlm.nih.gov/pubmed/36890471
http://dx.doi.org/10.1186/s12885-023-10693-w

Ejemplares similares